Bioengineering in organ transplantation: targeting the liver.

About 27,000 deaths are registered annually in the United States due to liver disease. At this time, the only definitive treatment of hepatic failure is orthotopic transplantation. However, there is a critical shortage of organs with the total waiting list for all organs currently at 100,000 requests. The number is increasing by 5% every year. Given that only organs in pristine condition are transplantable and that the hidden demand for organs as an anti-aging solution will be many times the current figures, orthotopic transplantation will always remain a limited pool. The increasing donor organ shortage requires consideration of alternative emerging technologies. Regenerative medicine may offer novel strategies to treat patients with end-stage organ failure. The ultimate aim of cell transplantation, tissue engineering, and stem cells is to regenerate tissues and organs. With the development of whole organ decellularization methods, the equation of organ shortage may dramatically change in the near future. Decellularized organs provide the ideal transplantable scaffold with all the necessary microstructure and extracellular cues for cell attachment, differentiation, vascularization, and function. New techniques to re-engineer organs may have major implications for the fields of drug discovery, regeneration biology, and ultimately organ transplantation. In this review we have provided an overview of complementary approaches to study and enhance the success of organ repopulation strategies creating new grafts/organs for transplantation.

[1]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[2]  Stephen F Badylak,et al.  An overview of tissue and whole organ decellularization processes. , 2011, Biomaterials.

[3]  Zhen W. Zhuang,et al.  Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.

[4]  R. Fisher,et al.  Human hepatocyte transplantation: worldwide results. , 2006, Transplantation.

[5]  Mårten K. J. Schneider,et al.  Xenotransplantation literature update June – October 2010 , 2010, Xenotransplantation.

[6]  K. Olthoff,et al.  Survival Following Liver Transplantation From Non-Heart-Beating Donors , 2004, Annals of surgery.

[7]  T. Solberg,et al.  Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation , 2009, Hepatology.

[8]  A. Hałoń,et al.  Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? , 2006, Transplantation proceedings.

[9]  Charles M. Miller,et al.  Adult Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: Extending UNOS Priority Criteria , 2004, Annals of surgery.

[10]  Melonie P. Heron,et al.  Deaths: preliminary data for 2004. , 2006, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[11]  Hiroshi Yagi,et al.  Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix , 2010, Nature Medicine.

[12]  C. Legallais,et al.  Artificial and bioartificial liver devices: present and future , 2009, Gut.

[13]  Stephen F Badylak,et al.  A whole-organ regenerative medicine approach for liver replacement. , 2011, Tissue engineering. Part C, Methods.

[14]  W. Marks,et al.  Organ donation and utilization in the United States, 2004 , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  E. Messersmith,et al.  Organ Donation and Utilization in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  K. Shakesheff,et al.  Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. , 2011, Journal of hepatology.

[17]  Christian Schuetz,et al.  Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.

[18]  C. Fondevila,et al.  In-vivo normothermic recirculation: an update , 2010, Current opinion in organ transplantation.

[19]  H. Yagi,et al.  Cell Delivery: From Cell Transplantation to Organ Engineering , 2010, Cell transplantation.

[20]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.